BrainZ's next-gen infant brain monitor:
This article was originally published in Clinica
Executive Summary
BrainZ Instruments has CE marked for sale in Europe a next-generation version of its bedside infant brain monitor. The BRM3 will be launched onto the European and Middle Eastern markets by the firm's distribution partner GE Healthcare, at the beginning of September. New features of the BRM3 include the option to attach a printer, a redesigned data acquisition unit with expanded features, a summary printout designed to be inserted into the patient record and USB 2.0 compatibility, said the Auckland, New Zealand firm. A US launch of the product will follow 510(k) clearance from the FDA, which is currently underway.
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.